未登录Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32癌抗原15-3与加拿大癌症试验组MA.32中免疫组化定义的乳腺癌亚型远处复发的关系
Pamela J Goodwin, MD; Bingshu E Chen, PhD; Karen A Gelmon, MD; Timothy J Whelan, BM, BCh; Marguerite Ennis, PhD; Jennifer Ligibel, MD; Paul M Stos, BSc (Hon); Lois E Shepherd, MD; Wendy R Parulekar, MD; Vuk Stambolic, PhD .png)
分享.png)
收藏Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32探索BMI和循环代谢因子作为CCTG MA.32研究中二甲双胍获益的预测指标Pamela J Goodwin, MD; Marguerite Ennis, PhD; Bingshu E Chen, PhD; Karen A Gelmon, MD; Timothy J Whelan, MD; Jennifer A Ligibel, MD; Alastair M Thompson, MBChB MD; Lois E Shepherd, MD; Wendy R Parulekar, MD; Ryan Dowling, PhD; Vuk Stambolic, PhD 分享 收藏 分享 收藏 Adjunctive statistical standardization of quantitated machine image analysis of Estrogen and Progesterone Receptors: CCTG MA.27 trialChapman, Judy-Anne; Bayani, Jane; SenGupta, Sandip; Bartlett, John M. S.; Piper, Tammy; Quintayo, Mary Anne; Virk, Shakeel; Goss, Paul; Ingle, James; Ellis, Matthew; Sledge, George, Jr.; Budd, George; Rabaglio, Manuela; Ansari, Rafat; Tozer, Richard; D'Souza, David; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Gelmon, Karen; Whelan, Timothy; Elliott, Catherine; Shepherd, Lois; Chen, Bingshu; Taylor, Karen 分享 收藏 分享 收藏 CCTG MA40: DOUBLE-BLIND PLACEBO CONTROLLED PHASE III TRIAL OF FULVESTRANT AND IPATASERTIB FOR ADVANCED HER-2 NEGATIVE AND ESTROGEN RECEPTOR POSITIVE (ER plus ) BREAST CANCER POST FIRST LINE CDK 4/6 AND AROMATASE INHIBITOR THERAPY (FINER)Chia, Stephen K.; Cescon, David W.; Redfern, Andrew D.; Rodin, Danielle; Simmons, Christine; Ayoub, Jean-Pierre; Chalchal, Haji Ibrahim; Rayson, Daniel; Rushton-Marovac, Moira; Hay, Tracey; Gallinaro, Lisa; Chen, Bingshu; Parulekar, Wendy 分享 收藏 Serum thymidine kinase activity as a prognostic marker in women with metastatic breast cancer treated with two different schedules of palbociclib plus second-line endocrine therapy within the CCTG MA38 trialMcCartney, Amelia; Biagioni, Chiara; Chen, Bingshu; Shepherd, Lois; Gelmon, Karen; Joy, Anil A.; Parulekar, Wendy; Bergqvist, Mattias; Migliaccio, Ilenia; Leo, Angela; Benelli, Matteo; Risi, Emanuela; Moretti, Erica; Livraghi, Luca; Biganzoli, Laura; Malorni, Luca 分享 收藏 Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trialRiaz, Nazia; Chen, Bingshu; Bane, Anita; Gao, Dongxia; Stovgaard, Elisabeth; Kos, Zuzana; Leung, Samuel; Shenasa, Elahe; Parulekar, Wendy; Chambers, Shelley; Nielson, Torsten; Whelan, Timothy J. 分享 收藏 Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer The MA.32 Randomized Clinical TrialGoodwin, Pamela J.; Chen, Bingshu E.; Gelmon, Karen A.; Whelan, Timothy J.; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A.; Hershman, Dawn L.; Mayer, Ingrid A.; Hobday, Timothy J.; Bliss, Judith M.; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D.; Mackey, John R.; Abramson, Vandana G.; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M.; Rea, Daniel W.; Stos, Paul M.; Shepherd, Lois E.; Stambolic, Vuk; Parulekar, Wendy R. 分享 收藏 CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438)Goodwin, Pamela J.; Chen, Bingshu E.; Gelmon, Karen A.; Whelan, Timothy J.; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A.; Hershman, Dawn L.; Mayer, Ingrid A.; Hobday, Timothy J.; Bliss, Judith M.; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D.; Mackey, Robert R.; Abramson, Vandana G.; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M.; Rea, Daniel W.; Stos, Paul M.; Shepherd, Lois E.; Stambolic, Vuk; Parulekar, Wendy R. 分享 收藏 Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials通过更频繁的给药或序贯方案增加化疗的剂量强度: 对26项随机试验中37298名早期乳腺癌女性患者的患者水平荟萃分析Boddington, C.; Bradley, R.; Braybrooke, J.; Burrett, J.; Clarke, M.; Davies, C.; Davies, L.; Dodwell, D.; Duane, F.; Evans, V.; Gettins, L.; Godwin, J.; Gray, R.; Hills, R.; James, S.; Liu, H.; Liu, Z.; MacKinnon, E.; Mannu, G.; McGale, P.; McHugh, T.; Morris, P.; Pan, H.; Peto, R.; Read, S.; Taylor, C.; Wang, Y.; Wang, Z.; Bradley, R.; Braybrooke, J.; Gray, R.; Bergh, J.; Peto, R.; Gray, Richard; Bradley, Rosie; Braybrooke, Jeremy; Liu, Zulian; Peto, Richard; Davies, Lucy; Dodwell, David; McGale, Paul; Pan, Hongchao; Taylor, Carolyn; Barlow, William; Bliss, Judith; Bruzzi, Paolo; Cameron, David; Fountzilas, George; Loibl, Sibylle; Mackey, John; Martin, Miguel; Del Mastro, Lucia; Moebus, Volker; Nekljudova, Valentina; De Placido, Sabino; Swain, Sandra; Untch, Michael; Pritchard, Kathleen I.; Bergh, Jonas; Norton, Larry; Fasching, P.; Harbeck, N.; Untch, M.; Piedbois, P.; Gnant, M.; Steger, G.; Di Leo, A.; Dolci, S.; Francis, P.; Larsimont, D.; Nogaret, J. M.; Philippson, C.; Piccart-Gebhart, M. J.; Linn, S.; Peer, P.; Tjan-Heijnen, V.; Vliek, S.; Mackey, J.; Martin, M.; Slamon, D.; Bartlett, J. M. S.; Bramwell, V. H.; Chen, B. E.; Chia, S. K. L.; Gelmon, K.; Goss, P. E.; Levine, M. N.; Parulekar, W.; Pater, J. L.; Pritchard, K. I.; Rakovitch, E.; Shepherd, L. E.; Tu, D.; Whelan, T.; Berry, D.; Broadwater, G.; Cirrincione, C.; Muss, H.; Norton, L.; Weiss, R. B.; Shan, Y.; Shao, Y. F.; Wang, X.; Xu, B.; Zhao, D. B.; Bartelink, H.; Bijker, N.; Bogaerts, J.; Cardoso, F.; Cufer, T.; Julien, J. P.; Poortmans, P. M.; Rutgers, E.; van de Velde, C. J. H.; Carrasco, E.; Martin, M.; Segui, M. A.; Blohmer, J. U.; Costa, S. D.; Gerber, B.; Jackisch, C.; Loibl, S.; Nekljudova, V.; von Minckwitz, G.; Bruzzi, P.; Giuliano, M.; De laurentiis, M.; De Placido, S.; Del Mastro, L.; Bamia, C.; Fountzilas, G.; Koliou, G-A; Mavroudis, D.; A'Hern, R.; Bliss, J.; Cameron, D.; Ellis, P.; Kilburn, L.; Morden, J.; Yarnold, J. R.; Sadoon, M.; Tulusan, A. H.; Anderson, S.; Bass, G.; Costantino, J.; Dignam, J.; Fisher, B.; Geyer, C.; Mamounas, E. P.; Paik, S.; Redmond, C.; Swain, S.; Wickerham, L.; Wolmark, N.; Del Mastro, L.; Venturini, M.; Bighin, C.; Bruzzi, P.; Del Mastro, L.; Pastorino, S.; Pronzato, P.; Sertoli, M. R.; Barlow, W.; Bergh, J.; Foukakis, T.; Pritchard, K. I.; Swain, S.; Cameron, D.; Albain, K.; Anderson, S.; Arriagada, R.; Barlow, W.; Bartlett, J.; Bergsten-Nordstrom, E.; Bliss, J.; Boccardo, F.; Bradley, R.; Brain, E.; Braybrooke, J.; Carey, L.; Clarke, M.; Coates, A.; Coleman, R.; Correa, C.; Costantino, J.; Cuzick, J.; Davidson, N.; Davies, C.; Davies, L.; Di Leo, A.; Dodwell, D.; Dowsett, M.; Duane, F.; Ewertz, M.; Forbes, J.; Francis, P.; Gelber, R.; Gnant, M.; Goldhirsch, A.; Goodwin, P.; Gray, R.; Hayes, D.; Hill, C.; Ingle, J.; Jagsi, R.; Janni, W.; Liu, Z.; Loibl, S.; MacKinnon, E.; Mannu, G.; Martin, M.; McGale, P.; Mukai, H.; Nekljudova, V.; Norton, L.; Ohashi, Y.; Paik, S.; Pan, H.; Peto, R.; Piccart, M.; Pierce, L.; Poortmans, P.; Raina, V.; Ravdin, P.; Rea, D.; Regan, M.; Robertson, J.; Rutgers, E.; Slamon, D.; Sparano, J.; Steger, G.; Taylor, C.; Tutt, A.; Viale, G.; Wang, X.; Whelan, T.; Wilcken, N.; Wolmark, N.; Wood, W.; Zambetti, M. 分享 收藏 分享 收藏 A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphomaBosch, Mark; Akhter, Ariz; Chen, Bingshu E.; Mansoor, Adnan; Lebrun, David; Good, David; Crump, Michael; Shepherd, Lois; Scott, David W.; Stewart, Douglas A. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Regional Nodal Irradiation in Early-Stage Breast CancerWhelan, Timothy J.; Olivotto, Ivo A.; Parulekar, Wendy R.; Ackerman, Ida; Chua, Boon H.; Nabid, Abdenour; Vallis, Katherine A.; White, Julia R.; Rousseau, Pierre; Fortin, Andre; Pierce, Lori J.; Manchul, Lee; Chafe, Susan; Nolan, Maureen C.; Craighead, Peter; Bowen, Julie; McCready, David R.; Pritchard, Kathleen I.; Gelmon, Karen; Murray, Yvonne; Chapman, Judy-Anne W.; Chen, Bingshu E.; Levine, Mark N. 分享 收藏 Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12Cheung, Matthew C.; Hay, Annette E.; Crump, Michael; Imrie, Kevin R.; Song, Yuyao; Hassan, Shazia; Risebrough, Nancy; Sussman, Jonathan; Couban, Stephen; MacDonald, David; Kukreti, Vishal; Kouroukis, C. Tom; Baetz, Tara; Szwajcer, David; Desjardins, Pierre; Shepherd, Lois; Meyer, Ralph M.; Le, Al; Chen, Bingshu E.; Mittmann, Nicole 分享 收藏 Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U)再照射治疗疼痛性骨转移对尿中破骨细胞活性标志物 (NCIC CTG SC.20U) 的影响Chow, Edward; DeAngelis, Carlo; Chen, Bingshu E.; Azad, Azar; Meyer, Ralph M.; Wilson, Carolyn; Kerba, Marc; Bezjak, Andrea; Wilson, Paula; Nabid, Abdenour; Greenland, Jonathan; Rees, Gareth; Vieth, Reinhold; Wong, Rebecca K. S.; Hoskin, Peter 分享 收藏 Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32Goodwin, Pamela J.; Parulekar, Wendy R.; Gelmon, Karen A.; Shepherd, Lois E.; Ligibel, Jennifer A.; Hershman, Dawn L.; Rastogi, Priya; Mayer, Ingrid A.; Hobday, Timothy J.; Lemieux, Julie; Thompson, Alastair M.; Pritchard, Kathleen I.; Whelan, Timothy J.; Mukherjee, Som D.; Chalchal, Haji I.; Oja, Conrad D.; Tonkin, Katia S.; Bernstein, Vanessa; Chen, Bingshu E.; Stambolic, Vuk 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
